Literature DB >> 11986338

A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours.

R Ranaldi1, G Goteri, M G Baccarini, B Mannello, I Bearzi.   

Abstract

AIMS: To describe the clinicopathological features of a large number of surgically treated and followed up primary gastric lymphomas and thereby gain a better understanding of their biology, with particular reference to the prognostic factors of high grade tumours.
METHODS: A retrospective study of 152 patients.
RESULTS: High grade gastric lymphomas, both pure and with a residual low grade component, differed from low grade mucosa associated lymphoid tissue (MALT)-type lymphomas in that they were more frequently large, ulcerated, at an advanced stage, and highly proliferating. In addition, patients were older and had a worse outcome. The prognosis of high grade lymphomas was influenced by patient age, tumour stage, depth of infiltration in the gastric wall, and the invasion of adjacent organs. Adjuvant postsurgical treatment prolonged survival only in patients with advanced stage and deep neoplastic infiltration.
CONCLUSIONS: There is a sharp distinction between low grade MALT-type lymphomas and tumours with a high grade component, justifying their different treatment approach. The postsurgical management of high grade lymphomas should be based on the accurate evaluation of the neoplastic extension.

Entities:  

Mesh:

Year:  2002        PMID: 11986338      PMCID: PMC1769653          DOI: 10.1136/jcp.55.5.346

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  35 in total

1.  Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters.

Authors:  J Krugmann; S Dirnhofer; A Gschwendtner; U Berresheim; R Greil; K Krugmann; F Fend
Journal:  Pathol Res Pract       Date:  2001       Impact factor: 3.250

2.  Prognostic value of histologic and clinical factors in 56 patients with gastrointestinal lymphomas.

Authors:  K Aozasa; T Ueda; A Kurata; C W Kim; M Inoue; N Matsuura; T Takeuchi; T Tsujimura; M E Kadin
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

Review 3.  Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.

Authors:  M B Azab; M Henry-Amar; P Rougier; C Bognel; C Theodore; P Carde; P Lasser; J M Cosset; B Caillou; J P Droz
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

4.  [Clinical staging classification of non-Hodgkin's lymphomas (author's transl)].

Authors:  K Musshoff
Journal:  Strahlentherapie       Date:  1977-04

5.  Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas.

Authors:  A J Ferreri; M Freschi; S Dell'Oro; E Viale; E Villa; M Ponzoni
Journal:  Am J Surg Pathol       Date:  2001-01       Impact factor: 6.394

6.  Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.

Authors:  A Ruskoné-Fourmestraux; A Lavergne; P H Aegerter; F Megraud; L Palazzo; A de Mascarel; T Molina; J L Rambaud
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

7.  Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review.

Authors:  J J Brooks; H T Enterline
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

8.  Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases.

Authors:  B Dragosics; P Bauer; T Radaszkiewicz
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

9.  Stages IE and IIE non-Hodgkin's lymphomas of the stomach. Comparison of treatment modalities.

Authors:  M H Maor; B Maddux; B M Osborne; L M Fuller; J A Sullivan; R S Nelson; R G Martin; H I Libshitz; W S Velasquez; R W Bennett
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

10.  Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry.

Authors:  R Otter; R Bieger; P M Kluin; J Hermans; R Willemze
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

View more
  6 in total

1.  Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.

Authors:  Agustín Avilés; Natividad Neri; M Jesús Nambo; Judith Huerta-Guzman; Sergio Cleto
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  The role of surgery in primary gastric lymphoma: results of a controlled clinical trial.

Authors:  Agustin Avilés; M Jesús Nambo; Natividad Neri; Judith Huerta-Guzmán; Ivonne Cuadra; Isabel Alvarado; Claudia Castañeda; Raúl Fernández; Martha González
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

3.  Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas.

Authors:  J Krugmann; A Tzankov; S Dirnhofer; F Fend; R Greil; R Siebert; M Erdel
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

4.  MALT Lymphomas.

Authors:  Sami N Malek; Amy J Hatfield; Ian W Flinn
Journal:  Curr Treat Options Oncol       Date:  2003-08

Review 5.  Gastrointestinal lymphoma.

Authors:  Philip J Bierman
Journal:  Curr Treat Options Oncol       Date:  2003-10

6.  Evaluation of the clinical characteristics, management, and prognosis of 103 patients with gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Xiaowu Li; Xiang Wang; Zhongli Zhan; Lianyu Zhang; Baochun Sun; Yizhuo Zhang
Journal:  Oncol Lett       Date:  2016-01-19       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.